Measurement of Antibodies to Interferon Beta in Patients With Multiple Sclerosis
Arch Neurol 58:1299-1300,1301, Pachner,A.R., 2001
The Significance of Neutralizing Antibodies in Patients With Multiple Sclerosis Treated With Interferon Beta
Arch Neurol 58:1297-1298,1301, Rice,G., 2001
MRI Features of Primary Central Nervous System Lymphomas at Presentation
Neurol 57:393-396, Buhring,U.,et al, 2001
Neurolymphomatosis of the Lumbar Plexus:High-Resolution MR Neurography Findings
Neurol 57:740-742, Moore,K.R.,et al, 2001
Primary Central Nervous System T-Cell Lymphoma
Neurol 57:716-718, Gijtenbeek,J.M.M.,et al, 2001
Postgastrectomy Polyneuropathy with Thiamine Deficiency
JNNP 71:357-362, Koike,H.,et al, 2001
Practice Patterns of Neurologists Regarding Bone and Mineral Effefcts of Antiepileptic Drug Therapy
Arch Neurol 58:1369-1374,1352, Valmadrid,C.,et al, 2001
Human Herpesvirus 6 Limbic Encephalitis After Stem Cell Transplantation
Ann Neurol 50:612-619, Wainwright,M.S.,et al, 2001
Cystic Fibrosis Presenting With Intracerebral Haemorrhage
Lancet 358:1960, Merelle,M.E.,et al, 2001
Hypotension and Cognitive Impairment
Neurol 57:1986-1992,1945, Zuccala,G.,et al, 2001
The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001
Comparisons of Patient Self-report, Neurologic Examination, and Functional Impairment in MS
Neurol 56:934-937, Hoogervorst,E.L.J.,et al, 2001
Primary Lymphoma of the Central Nervous System: Typical and Atypical CT and MR Imaging Appearances
AJR 176:1319-1326, Erdag,N.,et al, 2001
The Expanding Spectrum of Herpesvirus Infections of the Nervous System
Brain Pathol 11:440-451, Kleinschmidt-DeMasters,B.K. &Gilden,D.H., 2001
Association of Primary Central Nervous System Lymphoma with Long-Term Azathioprine Therapy for Myasthenia Gravis?
Ann Neurol 47: 682-683, Herrlinger,U.,et al, 2000
Cytomegalovirus Ventriculoencephalitis Presenting as a Wernicke's Encephalopathy-like Sydrome
Neurol 55:1910-1913, Torgovnick,J.,et al, 2000
Marchiafava-Bignami Disease
Merrit's Neurology, L.P. Rowland Ed., Lippincott, Phila.:792, Miller,J.R., 2000
AIDS-Related Focal Brain Lesions in the Era of Highly Active Antiretroviral Therapy
Neurol 55:1194-1200, Ammassari,A.,et al, 2000
Primary Non-Hodgkin's Lymphoma of the Spinal Cord
Spine 26:2262-2264, Pels,H.,et al, 2000
Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects
NEJM 343:1608-1614, Hernandez-Dias,S.,et al, 2000
Gray Matter Heterotopia
Neurol 55:1603-1608, Barkovich,A.J. & Kuzniecky,R.I., 2000
Diagnostic Testing for Coagulopathies in Patients With Ischemic Stroke
Stroke 31:3067-3078, Bushnell,C.D. & Goldstein,L.B., 2000
Protein C Deficiency Related to Valproic Acid Therapy: A Possible Association with Childhood Stroke
J Pediatr 137:714-718, Gruppo,R.,et al, 2000
Wernicke-Korsakoff Encephalopathy and Polyneuropathy After Gastroplasty for Morbid Obesity
Arch Neurol 57:1356-1359, Cirignotta,F. et al, 2000
Multiple Sclerosis
NEJM 343:938-952, Noseworthy,J.H. et al, 2000
The Acute Behavioral Syndrome of Anterior Thalamic Infarction: A Prospective Study of 12 Cases
Ann Neurol 48:220-227, Chika-Schmid,F. & Bogousslavsky,J., 2000
Life-Threatening Tinnitus
Lancet 356:308, Javaheri,S. et al, 2000
Epstein-Barr Virus Infection
NEJM 343:481-492, Cohen,J.I., 2000
Acromegaly Caused by Secretion of Growth Hormone by a Non-Hodgkin's Lymphoma
NEJM 342:1871-1876, Beuschlein,F.,et al, 2000
Epilepsy, Broken Bones, and Fatty Stools
Lancet 355:1882, Drenth,J.P.H.,et al, 2000
Safe Feeding Methods in Stroke Patients
Lancet 355:1662-1663, Finestone,H.M., 2000
Occupational Exposure to Methyl Isobutyl Ketone Causes Lasting Impairment in Working Memory
Neurol 54:1853-1855, Grober,E.&Schaumburg,H.H., 2000
Effect of Interferon B-1b in MS, Assessment of Annual Accumulation of PD/T2 Activity on MRI
Neurol 54:200-206, Zhao,G.J.,et al, 2000
Role of Brain Biopsy in the Management of Focal Brain Lesions in HIV-Infected Patients
Neurol 54:993-997, Antinori,A.,et al, 2000
Diagnosis and Treatment of Intravascular Lymphomatosis
ArchNeurol 57:374-377, Baumann,T.P.,et al, 2000
Immune Cytopenias as the Presenting Finding in Primary Sjogrens Syndrome
QJM 93:825-829, Schattner,A.,et al, 2000
Testicular Lymphoma is Associated With a High Incidence of Extranodal Recurrence
Cancer 88:154-161, Fonseca,R.,et al., 2000
Guillain-Barre Syndrome in a Patient with Non-Hodgkins Lymphoma
Ann Oncol 11:217-220, Schwenk,D.Re.,et al, 2000
Neural-Tube Defects
NEJM 341:1509-1519,1485, Botto,L.D.,et al, 1999
Ibuprofen Treatment Versus Gradual Introduction of Interferon B-1b in patients with MS
Neurol 52:1893-1895, Rice,G.P.A.,et al, 1999
Encephalitis after Hepatitis B Vaccination, Recurrent Disseminated Encephalitis or MS?
Neurol 53:396-401, Tourbah,A.,et al, 1999
Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999
Dementia as the Most Common Presentation of Cortical-Basal Ganglionic Degeneration
Neurol 53:1969-1974, Grimes,D.A.,et al, 1999
Benign Acute Childhood Myositis, Laboratory and Clinical Features
Neurol 53:2127-2131, Mackay,M.T.,et al, 1999
Brain Biopsy in Patients with Acquired Immunodeficiency Syndrome, Diagnostic Value, Clinical Performance, and Survival Time
Arch Int Med 159:2590-2596, Hornef,M.W.,et al, 1999
Prethrombotic Disorders in Children with Arterial Ischemic Stroke and Sinovenous Thrombosis
Arch Neurol 56:967-971, Bonduel,M.,et al, 1999
Folic Acid for the Prevention of Neural Tube Defects
Pediartrics 104:325-327, Committee on Genetics, 1999
Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999
New Developments in the Neurobiology of the Tuberous Sclerosis Complex
Neurol 53:1384-1390, Crino,P.B.&Henske,E.P., 1999
Treatment Recommendations for Interferon-B in Multiple Sclerosis
JNNP 67:561-566, Polman,C.H.,et al, 1999